Key result
Monitored anesthesia care fails to reduce hospital length of stay versus general anesthesia in TAVR.
Why the study?
Observational studies suggesting that monitored anesthesia care improves hospital throughput in TAVR largely reflect earlier practice patterns with longer hospitalizations, evolving care pathways, and retrospective design limitations.
Does monitored anesthesia care reduce hospital length of stay, 30-day mortality, or ICU admission compared to general endotracheal anesthesia in patients undergoing elective transfemoral TAVR?
RCT (n=170)
1:1
No
Does monitored anesthesia care reduce hospital length of stay, 30-day mortality, or ICU admission compared to general endotracheal anesthesia in patients undergoing elective transfemoral TAVR?
In contemporary elective transfemoral TAVR practice, monitored anesthesia care does not significantly alter hospital length of stay, 30-day mortality, or ICU admission compared with general endotracheal anesthesia, supporting individualized anesthetic choice.
Answers are grounded in this paper and cite their sources.
Monitored anesthesia care offers no hospital length-of-stay advantage over general anesthesia in elective transfemoral TAVR; challenges prior observational data.
BACKGROUND: Observational studies have suggested that monitored anesthesia care (MAC) improves hospital throughput in transcatheter aortic valve replacement (TAVR), though these findings largely reflect earlier practice patterns with longer hospitalizations, evolving care pathways, and limitations inherent to retrospective designs. METHODS: We conducted a single-center, prospective randomized controlled trial of 170 patients undergoing elective transfemoral TAVR. Patients were randomized 1:1 to MAC or general endotracheal anesthesia (GETA) with intraoperative transesophageal echocardiography. The primary outcomes were hospital length of stay (LOS), 30-day mortality, and intensive care unit (ICU) admission. The secondary outcome was paravalvular regurgitation (PVR). Other prospectively tracked perioperative efficiency metrics included procedure time and operating room time. RESULTS: There was no significant difference in hospital LOS between the two groups (median difference in LOS, MAC vs GETA: 0.02 days (95% confidence interval [CI], –0.09 to 0.15 days); P = 0.631). There were no 30-day deaths in either group. ICU admission rates ( P = 0.634) were similar between arms. No significant differences were observed in PVR rates ( P = 0.934), procedure time ( P = 0.142), or operating room time ( P = 0.439). CONCLUSIONS: In a modern TAVR program, anesthetic technique did not influence hospital LOS or other clinical endpoints during the study. These findings suggest that the efficiency differences previously associated with MAC may not persist in current TAVR practice. Anesthetic choice can be individualized without substantially altering hospital throughput in similar practice settings.
No takes yet. Share an insight, caveat, or question.
Whitener et al. (2026) conducted an RCT in Aortic stenosis requiring transcatheter aortic valve replacement (TAVR) (n=170). Monitored anesthesia care (MAC) vs. General endotracheal anesthesia (GETA) with intraoperative transesophageal echocardiography was evaluated on Hospital length of stay (LOS), 30-day mortality, and intensive care unit (ICU) admission (Median difference 0.02 days, 95% CI -0.09 to 0.15, p=0.631). Monitored anesthesia care did not differ from general endotracheal anesthesia in hospital length of stay during TAVR.
Synapse has enriched 10 related papers. Consider them for comparative context: